Evoke Pharma, Inc. (EVOK)

USD 2.24

(-0.24%)

Operating Expenses Summary of Evoke Pharma, Inc.

  • Evoke Pharma, Inc.'s latest annual operating expenses in 2023 was 12.4 Million USD , up 25.04% from previous year.
  • Evoke Pharma, Inc.'s latest quarterly operating expenses in 2024 Q2 was 3.73 Million USD , up 18.74% from previous quarter.
  • Evoke Pharma, Inc. reported a annual operating expenses of 9.92 Million USD in annual operating expenses 2022, up 5.11% from previous year.
  • Evoke Pharma, Inc. reported a annual operating expenses of 9.44 Million USD in annual operating expenses 2021, down -27.28% from previous year.
  • Evoke Pharma, Inc. reported a quarterly operating expenses of 3.14 Million USD for 2024 Q1, down -10.29% from previous quarter.
  • Evoke Pharma, Inc. reported a quarterly operating expenses of 12.4 Million USD for 2023 FY, up 25.04% from previous quarter.

Annual Operating Expenses Chart of Evoke Pharma, Inc. (2023 - 2011)

Historical Annual Operating Expenses of Evoke Pharma, Inc. (2023 - 2011)

Year Operating Expenses Operating Expenses Growth
2023 12.4 Million USD 25.04%
2022 9.92 Million USD 5.11%
2021 9.44 Million USD -27.28%
2020 12.98 Million USD 81.48%
2019 7.15 Million USD -10.73%
2018 8.01 Million USD -28.64%
2017 11.23 Million USD 6.51%
2016 10.54 Million USD -10.78%
2015 11.81 Million USD -10.13%
2014 13.15 Million USD 405.42%
2013 2.6 Million USD 29.93%
2012 2 Million USD -17.07%
2011 2.41 Million USD 0.0%

Peer Operating Expenses Comparison of Evoke Pharma, Inc.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD -50.368%
Alpha Teknova, Inc. 45.85 Million USD 72.94%
ANI Pharmaceuticals, Inc. 195.98 Million USD 93.668%
Aquestive Therapeutics, Inc. 44.85 Million USD 72.333%
Collegium Pharmaceutical, Inc. 159.2 Million USD 92.205%
Cosmos Health Inc. 26.18 Million USD 52.6%
Journey Medical Corporation 54.59 Million USD 77.269%
Embecta Corp. 528.4 Million USD 97.651%
Esperion Therapeutics, Inc. 271.89 Million USD 95.436%
Dynavax Technologies Corporation 219.14 Million USD 94.337%
Intra-Cellular Therapies, Inc. 590 Million USD 97.897%
Pacira BioSciences, Inc. 326.37 Million USD 96.198%
PainReform Ltd. 9.58 Million USD -29.483%
Sunshine Biopharma, Inc. 13.12 Million USD 5.447%
Sunshine Biopharma, Inc. 13.12 Million USD 5.447%
SCYNEXIS, Inc. 51.84 Million USD 76.065%
Safety Shot Inc 12.1 Million USD -2.477%
China SXT Pharmaceuticals, Inc. 3.06 Million USD -304.33%
Procaps Group, S.A. 199.47 Million USD 93.779%
Theratechnologies Inc. 72.75 Million USD 82.943%
Harrow Health, Inc. 89.97 Million USD 86.207%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD -31.375%
Biofrontera Inc. 39.95 Million USD 68.944%
DURECT Corporation 43.71 Million USD 71.612%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 97.654%
Cronos Group Inc. 96.7 Million USD 87.168%
OptiNose, Inc. 85.1 Million USD 85.418%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 94.654%
Kala Pharmaceuticals, Inc. 39.15 Million USD 68.305%
RedHill Biopharma Ltd. -9.56 Million USD 229.794%
Organogenesis Holdings Inc. 314.13 Million USD 96.05%
Guardion Health Sciences, Inc. 9.73 Million USD -27.529%
Cumberland Pharmaceuticals Inc. 43.04 Million USD 71.168%
Radius Health, Inc. 265.92 Million USD 95.333%
Universe Pharmaceuticals INC 13.84 Million USD 10.347%
ProPhase Labs, Inc. 37.85 Million USD 67.215%
Phibro Animal Health Corporation 260.29 Million USD 95.233%
Procaps Group S.A. 187.24 Million USD 93.373%
Alvotech 285.43 Million USD 95.652%
TherapeuticsMD, Inc. 9.82 Million USD -26.307%
Viatris Inc. 5.96 Billion USD 99.792%
Rockwell Medical, Inc. 15.37 Million USD 19.282%
Aytu BioPharma, Inc. 59.84 Million USD 79.262%
SIGA Technologies, Inc. 22.04 Million USD 43.703%
Tilray Brands, Inc. 251.35 Million USD 95.063%
Lifecore Biomedical, Inc. 49.03 Million USD 74.694%
Shineco, Inc. 17.94 Million USD 30.858%
PetIQ, Inc. 192.72 Million USD 93.561%
Regencell Bioscience Holdings Limited 3.99 Million USD -210.93%
Incannex Healthcare Limited 30.05 Million USD 58.707%
Neurocrine Biosciences, Inc. 1.59 Billion USD 99.223%
Alimera Sciences, Inc. 62.64 Million USD 80.189%
Silver Spike Investment Corp. 762.49 Thousand USD -1527.511%
Assertio Holdings, Inc. 368.58 Million USD 96.633%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD -110.849%
Petros Pharmaceuticals, Inc. 17.8 Million USD 30.316%
Clever Leaves Holdings Inc. 21.16 Million USD 41.378%
Cyclo Therapeutics, Inc. 21.04 Million USD 41.025%
Avadel Pharmaceuticals plc 164.96 Million USD 92.477%
Hempacco Co., Inc. 7.59 Million USD -63.361%
Talphera, Inc. 11.99 Million USD -3.465%
Alvotech 285.43 Million USD 95.652%
Eagle Pharmaceuticals, Inc. 140.71 Million USD 91.181%
Lantheus Holdings, Inc. 344.9 Million USD 96.402%
Currenc Group, Inc. 24 Million USD 48.298%
Kamada Ltd. 45.42 Million USD 72.682%
Indivior PLC 911 Million USD 98.638%
Flora Growth Corp. 10.57 Million USD -17.304%
Cyclo Therapeutics, Inc. 21.04 Million USD 41.025%
Evolus, Inc. 189.75 Million USD 93.46%
HUTCHMED (China) Limited 436.23 Million USD 97.155%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 91.949%
Akanda Corp. 3.48 Million USD -256.24%